Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Antimicrobial Agents and Chemotherapy
|
March 22, 2017
Variability in Trough Total and Unbound Teicoplanin Concentrations and Achievement of Therapeutic Drug Monitoring Targets in Adult Patients with Hematological Malignancy
Catherine J Byrne, Jason A Roberts, Brett McWhinney, et al.
The Journal of Antimicrobial Chemotherapy
|
December 23, 2017
Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy
Catherine J Byrne, Ted Parton, Brett McWhinney, et al.
British Journal of Haematology
|
June 25, 2008
Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients
Belinda Austen, Giancarlo Barone, Anne Reiman, et al.
British Journal of Haematology
|
June 23, 2021
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations
Michelle Lavin, Patrick T Elder, Denis O'Keeffe, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 21, 2021
Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive Disorder
Laura McDonald, Roseann O' Doherty, Eileen Ryan, et al.
Leukemia & Lymphoma
|
September 20, 2017
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL
Niamh Appleby, David O'Brien, Fiona M Quinn, et al.
Clinical Hematology International
|
October 1, 2021
How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma
Treen Carson Michael Morris, Mary B Drake, Paul J Kettle, et al.
British Journal of Haematology
|
August 6, 2013
A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia
Su W Maung, Maeve Leahy, Hilary M O'Leary, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 11, 2018
Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic <i>ERCC6L2</i> variants
Hemanth Tummala, Arran D Dokal, Amanda Walne, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Antimicrobial Agents and Chemotherapy
|
March 22, 2017
Variability in Trough Total and Unbound Teicoplanin Concentrations and Achievement of Therapeutic Drug Monitoring Targets in Adult Patients with Hematological Malignancy
Catherine J Byrne, Jason A Roberts, Brett McWhinney, et al.
The Journal of Antimicrobial Chemotherapy
|
December 23, 2017
Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy
Catherine J Byrne, Ted Parton, Brett McWhinney, et al.
British Journal of Haematology
|
June 25, 2008
Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients
Belinda Austen, Giancarlo Barone, Anne Reiman, et al.
British Journal of Haematology
|
June 23, 2021
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations
Michelle Lavin, Patrick T Elder, Denis O'Keeffe, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 21, 2021
Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive Disorder
Laura McDonald, Roseann O' Doherty, Eileen Ryan, et al.
Leukemia & Lymphoma
|
September 20, 2017
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL
Niamh Appleby, David O'Brien, Fiona M Quinn, et al.
Clinical Hematology International
|
October 1, 2021
How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma
Treen Carson Michael Morris, Mary B Drake, Paul J Kettle, et al.
British Journal of Haematology
|
August 6, 2013
A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia
Su W Maung, Maeve Leahy, Hilary M O'Leary, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 11, 2018
Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic <i>ERCC6L2</i> variants
Hemanth Tummala, Arran D Dokal, Amanda Walne, et al.
Page
of 2